Smartee Raises US$80M in Series D Funding
Founded in 2004, Smartee focuses on the R&D of novel technologies in invisible digital orthodontics as well as the medical design, manufacturing, sales and services of custom clear aligners. Smartee has medical design centers with a team of hundreds of employees and has built self-developed full-process automatic intelligent manufacturing bases in Jiaxing, zhejiang province and Ziyang, Sichuan Province (Chinese Dental Valley). Smarted designed more than 500,000 enclosures so far and produces over 10 million invisible aligners per year to serve physicians and consumers around the world. Smartee is one of the leading brands in the invisible orthodontic industry in China and China’s leading clear aligner supplier with the largest overseas market share, expanding its business to markets such as the United States, CanadaColombia, MexicoUK, Spain, Portugal, Saudi Arabia, Egypt, Australia, Singapore, Philippines and Thailand etc
From Angel funding to Series D funding, over the past 18 years, Smartee has achieved fruitful results in many fields, such as new clinical technologies, new diagnosis classification, clear alignment materials, big data and algorithms, digital simulation technology, smart manufacturing, etc. to. From February 2022, more than 530 patents have been applied for at home and abroad. The number and quality of patents are ahead of its domestic counterparts. Smartee has become one of the well-known high-tech companies with innovation and growth in the dental industry.
Talking about the future, Mr. Yao Junfeng, the founder of Smartee, said “Smaree received the equity investment from RZJ Capital for the Angel Round in 2013, the Series A investment from CS Capital and KaVo in 2015, the Series B investment from bioVENTURE and CD Capital in 2017, and the Series C investment by CICC Capital, Neovision Capital, Costone Capital and Qianhai FOF in 2019. The company carefully manages the pace of funding and concentrates more about growing the business with business income. The completion of the Series D financing will undoubtedly accelerate the development of Smartee and support our strategic disposition. As a fast-growing Chinese Clear Aligner brand, Smartee will continue to invest in the R&D of invisible orthodontic technology, strive to inject more innovative ideas and energy into the industry, and enable more consumers for take advantage of state-of-the-art invisible orthodontic technology.”
Mr. Huang Shengxuan, CEO of Beijing Taikang Investment, said “After more than ten years of accumulation, Smartee Denti-Technology has established a solid leading position in the industry and maintained a growth rate far exceeding that of the market. Based on the deep technical cooperation between Smartee and Taikang Bybo, we will continue to promote business cooperation between Smartee, Taikang Insurance and Taikang Bybo, and jointly create a new ecological model of mutual synergy between insurance, oral medicine and innovative dental technology.”
Sir. Wang Xingeneral manager of China Resources Consumer Fund II, said “The rapid growth in Smartee’s case accumulation over the past few years is proof that the potential of the orthodontic industry is rapidly being unleashed. The fund team is honored to partner with the “Smartee team to participate in the development of the national invisible orthodontics industry. I believe that under the leadership of the founder, Mr. Yao Junfeng, Smartee will become an important player in the global orthodontic industry. With professional doctors of the industry, Smartee will strive to create greater development opportunities and provide better orthodontic services to patients around the world.”
For more information, please visit the company’s website at www.smartee.fr.
SOURCESmartee Denti-Technology Co., Ltd.